WallStSmart

HCA Healthcare, Inc. (HCA)vsCharming Medical Limited Class A Ordinary Shares (MCTA)

VS

Smart Verdict

WallStSmart Research — data-driven comparison

HCA Healthcare, Inc. generates 1622568% more annual revenue ($78.01B vs $4.81M). HCA leads profitability with a 8.8% profit margin vs -0.5%. HCA trades at a lower P/E of 14.3x. HCA earns a higher WallStSmart Score of 65/100 (C+).

HCA

Buy

65

out of 100

Grade: C+

Growth: 6.0Profit: 8.0Value: 5.3Quality: 6.0
Piotroski: 5/9Altman Z: 1.71

MCTA

Avoid

11

out of 100

Grade: F

Growth: 4.0Profit: 3.0Value: 4.0Quality: 5.0
Piotroski: 2/9
IV

Intrinsic Value Comparison

Multi-model valuation · Graham Formula

HCASignificantly Overvalued (-76.5%)

Margin of Safety

-76.5%

Fair Value

$301.11

Current Price

$426.94

$125.83 premium

UndervaluedFair: $301.11Overvalued

Intrinsic value data unavailable for MCTA.

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

HCA5 strengths · Avg: 9.0/10
Return on EquityProfitability
136.3%10/10

Every $100 of equity generates 136 in profit

Debt/EquityHealth
-7.4210/10

Conservative balance sheet, low leverage

Market CapQuality
$92.43B9/10

Large-cap with strong market position

P/E RatioValuation
14.3x8/10

Attractively priced relative to earnings

Free Cash FlowQuality
$1.10B8/10

Generating 1.1B in free cash flow

MCTA0 strengths · Avg: 0/10

No standout strengths identified

Areas to Watch

HCA1 concerns · Avg: 4.0/10
Altman Z-ScoreHealth
1.714/10

Distress zone — elevated risk

MCTA4 concerns · Avg: 2.8/10
Market CapQuality
$445.55M3/10

Smaller company, higher risk/reward

Operating MarginProfitability
4.9%3/10

Operating margin of 4.9%

Piotroski F-ScoreQuality
2/93/10

Weak financial health signals

P/E RatioValuation
419.4x2/10

Premium valuation, high expectations priced in

Comparative Analysis Report

WallStSmart Research

Bull Case : HCA

The strongest argument for HCA centers on Return on Equity, Debt/Equity, Market Cap. PEG of 1.29 suggests the stock is reasonably priced for its growth.

Bull Case : MCTA

MCTA has a balanced fundamental profile.

Bear Case : HCA

The primary concerns for HCA are Altman Z-Score.

Bear Case : MCTA

The primary concerns for MCTA are Market Cap, Operating Margin, Piotroski F-Score. A P/E of 419.4x leaves little room for execution misses.

Key Dynamics to Monitor

HCA profiles as a value stock while MCTA is a turnaround play — different risk/reward profiles.

HCA is growing revenue faster at 8.7% — sustainability is the question.

HCA generates stronger free cash flow (1.1B), providing more financial flexibility.

Monitor MEDICAL CARE FACILITIES industry trends, competitive dynamics, and regulatory changes.

Bottom Line

HCA scores higher overall (65/100 vs 11/100). Both earn "Buy" and "Avoid" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

HCA Healthcare, Inc.

HEALTHCARE · MEDICAL CARE FACILITIES · USA

HCA Healthcare is an American for-profit operator of health care facilities that was founded in 1968. It is based in Nashville, Tennessee, and, as of May 2020, owns and operates 186 hospitals and approximately 2,000 sites of care, including surgery centers, freestanding emergency rooms, urgent care centers and physician clinics in 21 states and the United Kingdom.

Visit Website →

Charming Medical Limited Class A Ordinary Shares

HEALTHCARE · MEDICAL CARE FACILITIES · USA

Charming Medical Limited, engage in the provision of beauty, wellness, and postpartum services under the Beauty Lab brand name in Hong Kong. The company is headquartered in Causeway Bay, Hong Kong.

Want to dig deeper into these stocks?